Medical education Snapshot
Cancer Ophthalmology
Volume 214 - Issue 7

An eyebrow lump: malignant spindle cell melanoma

Authors:  Tung T Hoang, Graham A Lee and Timothy J Sullivan

Med J Aust 2021; 214 (7): 306-306.e1. || doi: 10.5694/mja2.50989
Published online: 19 April 2021
An 88-year-old white woman presented with a subcutaneous mass on the left lateral brow
Download PDF
Share: Share on Blue Sky Share on Facebook Share on LinkedIn Share by email
An 88‐year‐old white woman presented with a subcutaneous mass on the left lateral brow (Figure, A). She had been aware of this lesion for the past 8 years, but it had increased in size over the past 2 months, and was associated with erythema and a sensation of paraesthesia. Orbital ultrasound revealed a well defined subcutaneous hypervascular lesion with no invasion in the adjacent structures, but the appearances were non‐specific. She underwent excision biopsy (Figure, B). Histopathology (Figure, C; left: interlacing fascicles of malignant spindle shaped cells with background chronic inflammatory cell infiltrate [haematoxylin and eosin stain]; right, immunoperoxidase stain showing strong nuclear positivity for SOX10, a marker of malignant melanoma) revealed a malignant spindle cell melanoma with no perineural involvement. Wider excision was performed with adjunctive radiotherapy to the tumour bed. The post‐operative positron emission tomography (PET) and computed tomography scans were clear. At 6 months, the site was well healed with a good cosmetic result (Figure, D). Spindle cell melanoma is a rare subtype of malignant melanoma. This case highlights the importance of histopathological confirmation and follow‐up adjunctive therapies.1

Authors

  • Tung T Hoang1,2
  • Graham A Lee3,4
  • Timothy J Sullivan4,5
  • 1. Hanoi Medical University, Hanoi, Vietnam
  • 2. Save Sight Institute, University of Sydney, Sydney, NSW
  • 3. City Eye Centre, Brisbane, QLD
  • 4. University of Queensland, Brisbane, QLD
  • 5. Royal Brisbane and Women’s Hospital Health Service District, Brisbane, QLD

Correspondence: eye@cityeye.com.au

Competing interests

No relevant disclosures.

References

View this article on Wiley Online Library

More like this

Cancer Research 18 August 2026 Open Access

Uneven Ground: Survival Differences Among Victorian Lung Cancer Patients by Location of Residence (2011–2023): A Retrospective Cohort Study

Evangeline Samuel, Eldho Paul, Mike Lloyd, Sanuki Tissera, Craig Underhill, Sagun Parakh, Phillip Parente, Inger Olesen, Javier Torres, Katharine See, Gavin M. Wright, David Langton, Thomas John, Matthew Conron, James Bartlett, Nicola Atkin, Nikolajs Zeps, Susan V. Harden, Wasek Faisal, John R. Zalcberg, Rob G. Stirling

Cancer Research 18 August 2026 Open Access

Early-Onset Colorectal Cancer With Liver-Only Metastases: A Retrospective Cohort Study Integrating Prospectively Collected Real-World Clinical and Molecular Data From an Australian National Database (2009–2024) to Guide Treatment Planning

Savio G. Barreto, Christos S. Karapetis, Shahid Ullah, Matthew Burge, Susan Caird, Angus Campbell, Azim Jalali, Ross Jennens, Muhammad A. Khattak, Belinda Lee, Stephanie H. Lim, Shehara Mendis, Louise Nott, Timothy J. Price, Jeremy D. Shapiro, Jeanne Tie, Javier Torres, Colin Williams, Rachel Wong, Vanessa Wong, Peter Gibbs

Cancer Guideline summary 13 July 2026 Open Access

Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in High-Risk Individuals in Australia

Nicole M. Rankin, Rebecca Zosel, Lisa J. Whop, Raglan Maddox, Annette McWilliams, Miranda Siemienowicz, Jon Emery, Maria A. R. Lantin, Georgia Bartlett, Mikayla Wolfe, Abbey Diaz, Katrina Anderson, Lillian Liu, Cindy Toms, Sarah McDermott, Peter Bligh, Jeremy Chalke, Stephen Melsom, Claire E. Nightingale, Alison Brown, Sam Pope, Julia Brotherton, Anne Fidler, Michel Itel, Mark Brooke, Diane M. Pascoe, Fraser Brims, Tracy L. Leong, Emily Stone, Dorothy Keefe, Vivienne Milch

View more